Johnson & Johnson Innovation - JJDC’s Legend Biotech LEGN Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$66.9M	Hold	1,629,173	–	–	6.84%	5
2021 Q1	$47.3M	Hold	1,629,173	–	–	6.12%	4
2020 Q4	$45.9M	Hold	1,629,173	–	–	5.92%	4
2020 Q3	$50.3M	Hold	1,629,173	–	–	10.12%	3
2020 Q2	$69.3M	Buy	+1,629,173	New	+$63.6M	13.62%	3

Other funds holding LEGN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's LEGN Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC held its Legend Biotech (LEGN) position steady in Q2 2021 at 1,629,173 shares worth $66.9M. The position accounts for 6.84% of the portfolio, ranked #5.

Johnson & Johnson Innovation - JJDC first reported a position in LEGN in Q2 2020 and has held it in 5 quarters since. The position peaked at $69.3M in Q2 2020. 86 funds tracked by Wall St. Rank hold LEGN as of Q2 2021.

Johnson & Johnson Innovation - JJDC held 1,629,173 shares of Legend Biotech worth $66.9M as of Q2 2021.
Johnson & Johnson Innovation - JJDC left its Legend Biotech share count unchanged in Q2 2021.
Legend Biotech made up 6.84% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #5 holding.
Johnson & Johnson Innovation - JJDC first reported a position in Legend Biotech in Q2 2020 and has held it in 5 quarters since.
Johnson & Johnson Innovation - JJDC's Legend Biotech position peaked at $69.3M in Q2 2020.
86 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.